This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2008-2010.
Location History:
- Monmouth, NJ (US) (2008)
- Monmouth Junction, NJ (US) (2009 - 2010)
Company Filing History:
Years Active: 2008-2010
Title: The Innovative Contributions of Rogelio L Martinez
Introduction
Rogelio L Martinez is a notable inventor based in Monmouth Junction, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and formulations. With a total of 3 patents to his name, Martinez has demonstrated a commitment to advancing medical science.
Latest Patents
Martinez's latest patents include groundbreaking work on fused cyclic succinimide compounds and their analogs. These compounds serve as modulators of nuclear hormone receptor function, with potential applications in treating conditions such as cancer and immune disorders. Additionally, he has developed sustained release GLP-1 receptor modulators, which are novel pharmaceutical compositions that utilize a human glucagon-like peptide-1 (GLP-1) receptor modulator as an active ingredient in a sustained release formulation.
Career Highlights
Martinez is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His work has the potential to impact the treatment of various diseases, showcasing his dedication to improving patient outcomes.
Collaborations
Throughout his career, Martinez has collaborated with esteemed colleagues, including William R Ewing and Claudio Mapelli. These partnerships have likely enhanced the scope and impact of his research.
Conclusion
Rogelio L Martinez is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in medical treatments. His innovative patents and collaborations reflect his dedication to improving healthcare through scientific research.